References
- Shemin D, Maaz D, St. Pierre D, Kahn SI, Chazan JA. Effect of aminoglycoside use on residual function in peritoneal dialysis patients. Am J Kidney Dis 1999; 34: 14–20
- Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, et al. Peritoneal dialysis-related infections recommendations: 2005 uptodate. Perit Dial Int 2005; 25: 107–31
- Gokal R. Infectious complications and peritonitis and their management. Complications of Dialysis, N Lameire, RL Mehta. Marcel Dekker Inc, New York, Basel 2000; 195–214
- Maiorca R, Vonesh EF, Cavalli PL, De Vecchi A, Giangrande A, La Greca G, et al. A multicentre, selection-adjusted comparison of patient and technique survivals on CAPD and haemodialysis. Perit Dial Int 1991; 11: 118–27
- Montagnac R, Slingeneyer A, Schillinger F. Aseptic peritonitis: role of icodextrin. Nephrol Dial Transplant 2001; 16: 435–6
- Fiedler R, Schneider I, Buchmann J, Osten B, Langer T. Does peritoneal dialysis predispose a diabetic patient to icodextrin-induced peritonitis?. Nephrol Dial Transplant 2002; 17: 1708–9
- MacGinley R, Cooney K, Alexander G, Cohen S, Goldsmith DJA. Relapsing culture-negative peritonitis in peritoneal dialysis patients exposed to icodextrin solution. Am J Kidney Dis 2002; 40: 1030–5
- Glorieux G, Lameire N, van Biesen W, Dequidt C, Vanholder R. Specific characteristics of peritoneal leucocyte populations during sterile peritonitis with icodextrin CAPD fluids. Neprol Dial Transplant 2003; 18: 1648–53
- van Biesen W, Vanholder R, Vogelaers D, Peleman R, Verschragen G, Vijt D, Lameire N. The need for centre tailored treatment of protocol of peritonitis. Perit Dial Int 1998; 18: 274–81
- Holley JL, Bernadini J, Piraino B. Infecting organisms in CAPD patients on the Y set. Am J Kidney Dis 1994; 23: 569–73
- Daly CD, Campbell MK, MacLeod AM, Cody DJ, Vale LD, Grant AM, et al. Do the Y-set and double-bag systems reduce the incidence of CAPD peritonitis?. Nephrol Dial Transplant 2001; 16: 341–7
- Thodis E, Bhaskaran S, Pasadakis P, Bargman JM, Vas SI, Oreopoulos DG. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site. Perit Dial Int 1998; 18: 261–70
- Perez-Fontan M, Rodriguez-Carmona A, Rosales M, Garcia-Falcon T, Valdes F. Incidence and clinical significance of nasal pericatheter colonization by Gram-negative bacteria among patients undergoing chronic peritoneal dialysis. Nephrol Dial Transplant 2002; 17: 118–22
- Piraino B, Bernardini J, Florio T, Fried L. Staphylococcus aureus prophylaxis and trends in Gram-negative infections in peritoneal dialysis patients. Perit Dial Int 2003; 23: 456–9
- Baker RJ, Senior H, Clemenger M, Brown EA. Empirical aminoglycosides for peritonitis do not affect residual renal function. Am J Kidney Dis 2003; 41: 670–5